Trial · NCT02213055
Pediatric Head Lice Study Product Comparison
NCT02213055, Phase 2, Completed, Hackensack Meridian Health; results first posted 2016-07-29
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Pediatric Head Lice Study Product Comparison. Trials, record NCT02213055. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02213055
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Pediatric Head Lice Study Product Comparison
- NCT number
- NCT02213055
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 97 participants, actual
- Lead sponsor
- Hackensack Meridian Health
- Conditions
- Head Lice
- Interventions
- LICEMD, Standard Head lice product
- First posted
- 2014-08-11
- Last updated
- 2016-07-29
- Results first posted
- 2016-07-29
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants Free of Live Head Lice and Free of Viable Eggs | Day after first treatment and Day 14 of study | A determination of head lice effectiveness, measured by number of subjects free of live lice and by number of subjects free of viable eggs, was calculated using two week post-treatment data as the primary study outcome. Measurements were calculated at Day 1 (day after first treatment) and Day 14. At diagnosis, 55 subjects had viable eggs with three subjects meeting enrollment criteria for three or more live lice. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants Free of Live Head Lice and Free of Viable Eggs | Day after first treatment and Day 14 of study | There were 58 evaluable subjects in the experimental (LiceMD) arm of the study. | Participants | NUMBER |
Source ClinicalTrials.gov
Results by group4
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants Free of Live Head Lice and Free of Viable Eggs | LiceMD | Day 1 Free of live lice | 57 | Participants | |
| Number of Participants Free of Live Head Lice and Free of Viable Eggs | LiceMD | Day 14 Free of live lice | 55 | Participants | |
| Number of Participants Free of Live Head Lice and Free of Viable Eggs | LiceMD | Day 1 Free of viable eggs | 32 | Participants | |
| Number of Participants Free of Live Head Lice and Free of Viable Eggs | LiceMD | Day 14 Free of viable eggs | 46 | Participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | LICEMD | 97 | |
| Overall Study | STARTED | Standard Head Lice Product | 0 | |
| Overall Study | COMPLETED | LICEMD | 58 | |
| Overall Study | COMPLETED | Standard Head Lice Product | 0 | |
| Overall Study | NOT COMPLETED | LICEMD | 39 | |
| Overall Study | NOT COMPLETED | Standard Head Lice Product | 0 |
Source ClinicalTrials.gov
Adverse events2
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Skin irritation | Skin and subcutaneous tissue disorders | LiceMD | 1 | 97 | 1 |
| other | Skin irritation | Skin and subcutaneous tissue disorders | Standard Head Lice Product | 0 | 0 | 0 |
Source ClinicalTrials.gov
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | LiceMD | ||
| Total, all-cause mortality | Standard Head Lice Product | ||
| Total, other adverse events | LiceMD | 1 | 97 |
| Total, other adverse events | Standard Head Lice Product | 0 | 0 |
| Total, serious adverse events | LiceMD | 0 | 97 |
| Total, serious adverse events | Standard Head Lice Product | 0 | 0 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 26092045 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02213055
GET https://conductscience.org/api/trials/v1/NCT02213055/registered